| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,368 | 8,120 | 8,421 | 5,222 | | Cost of Revenue | 3,269 | 3,664 | 3,404 | 2,615 | | | Gross Profit | 1,099 | 4,456 | 5,017 | 2,607 | | | Operating Expenses | | Research Development | 1,797 | 1,930 | 2,025 | 1,851 | | Selling General and Administrative | 2,090 | 2,722 | 2,662 | 2,372 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,788) | (196) | 330 | (1,616) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 62 | 75 | 97 | 49 | | Earnings Before Interest And Taxes | (2,726) | (121) | 427 | (1,567) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,726) | (121) | 427 | (1,567) | | Income Tax Expense | (345) | (195) | (280) | (285) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,381) | 74 | 707 | (1,282) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,381) | 74 | 707 | (1,282) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,381) | $74 | $707 | ($1,282) |
|
0.49% Nasdaq 
Income Statement
